These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Epstein-Barr virus infection and variants of Epstein-Barr nuclear antigen-1 in synovial tissues of rheumatoid arthritis. Masuoka S; Kusunoki N; Takamatsu R; Takahashi H; Tsuchiya K; Kawai S; Nanki T PLoS One; 2018; 13(12):e0208957. PubMed ID: 30533036 [TBL] [Abstract][Full Text] [Related]
31. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Banwell B; Bar-Or A; Arnold DL; Sadovnick D; Narayanan S; McGowan M; O'Mahony J; Magalhaes S; Hanwell H; Vieth R; Tellier R; Vincent T; Disanto G; Ebers G; Wambera K; Connolly MB; Yager J; Mah JK; Booth F; Sebire G; Callen D; Meaney B; Dilenge ME; Lortie A; Pohl D; Doja A; Venketaswaran S; Levin S; Macdonald EA; Meek D; Wood E; Lowry N; Buckley D; Yim C; Awuku M; Cooper P; Grand'maison F; Baird JB; Bhan V; Marrie RA Lancet Neurol; 2011 May; 10(5):436-45. PubMed ID: 21459044 [TBL] [Abstract][Full Text] [Related]
32. Systematic review and meta-analysis of the association between Epstein-Barr virus, multiple sclerosis and other risk factors. Jacobs BM; Giovannoni G; Cuzick J; Dobson R Mult Scler; 2020 Oct; 26(11):1281-1297. PubMed ID: 32202208 [TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation. Serafini B; Severa M; Columba-Cabezas S; Rosicarelli B; Veroni C; Chiappetta G; Magliozzi R; Reynolds R; Coccia EM; Aloisi F J Neuropathol Exp Neurol; 2010 Jul; 69(7):677-93. PubMed ID: 20535037 [TBL] [Abstract][Full Text] [Related]
36. EBV Infection and Multiple Sclerosis: Lessons from a Marmoset Model. 'tHart BA; Kap YS; Morandi E; Laman JD; Gran B Trends Mol Med; 2016 Dec; 22(12):1012-1024. PubMed ID: 27836419 [TBL] [Abstract][Full Text] [Related]
37. The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review. Ruprecht K Expert Rev Clin Immunol; 2020 Dec; 16(12):1143-1157. PubMed ID: 33152255 [No Abstract] [Full Text] [Related]
38. Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis. Otto C; Hofmann J; Ruprecht K Med Hypotheses; 2016 Jun; 91():109-113. PubMed ID: 27142157 [TBL] [Abstract][Full Text] [Related]
39. HLA DR2b-binding peptides from human endogenous retrovirus envelope, Epstein-Barr virus and brain proteins in the context of molecular mimicry in multiple sclerosis. Ramasamy R; Mohammed F; Meier UC Immunol Lett; 2020 Jan; 217():15-24. PubMed ID: 31689443 [TBL] [Abstract][Full Text] [Related]
40. Two Epstein-Barr virus glycoprotein complexes. Hutt-Fletcher LM; Lake CM Curr Top Microbiol Immunol; 2001; 258():51-64. PubMed ID: 11443867 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]